Kodiak Sciences Inc. SEC filings KOD
Kodiak Sciences Inc. has 422 filings in SEC EDGAR's recent list, going back to Jul 28, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Mar 27, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2023 | Aug 16, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 23, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 15, 2021 | Oct 13, 2021 |
| 8-K |
Current report
Other events
|
Sep 1, 2021 | Sep 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 23, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Other events
|
Nov 18, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
New debt
|
Aug 20, 2020 | Aug 14, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 8, 2020 |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2020 | Apr 2, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Other events
|
Dec 4, 2019 | Dec 3, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 2, 2019 | Dec 1, 2019 |
| 8-K |
Current report
Other events
|
Nov 20, 2019 | Nov 18, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Other events
|
Oct 15, 2019 | Oct 11, 2019 |
| 8-K |
Current report
Listing notice
|
Oct 10, 2019 | Oct 4, 2019 |
| 8-K |
Current report
Other events
|
Sep 12, 2019 | Sep 6, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
| 8-K |
Current report
Other events
|
Jul 29, 2019 | Jul 27, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Results of operations
|
May 15, 2019 | May 15, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2019 | Mar 28, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 5, 2019 | Jan 30, 2019 |
| 8-K |
Current report
Change to shareholder rights, Other events
|
Jan 28, 2019 | Jan 22, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2018 | Nov 16, 2018 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KOD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1468748
- Former names
- Oligasis, LLC (until Jul 28, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.